Difference between revisions of "Team:NCTU Formosa"

Line 42: Line 42:
 
.div3-1{
 
.div3-1{
 
         background:#fff;
 
         background:#fff;
−
         width:28vw;
+
         width:28%;
−
height:25vw;
+
height:23vw;
 
         position:absolute;
 
         position:absolute;
 
         left:8%;
 
         left:8%;
Line 51: Line 51:
 
         .div3-2{
 
         .div3-2{
 
         background:#fff;
 
         background:#fff;
−
         width:28vw;
+
         width:28%;
−
height:25vw;
+
height:23vw;
 
 
 
position:absolute;
 
position:absolute;
Line 61: Line 61:
 
         .div3-3{
 
         .div3-3{
 
         background:#fff;
 
         background:#fff;
−
         width:28vw;
+
         width:28%;
−
height:25vw;
+
height:23vw;
 
 
 
position:absolute;
 
position:absolute;

Revision as of 15:16, 18 September 2015

The only thing we can detect is everything.

Who are we

NCTU_Formosa created an organization-APOllO, which stands for Almighty Probe of scFv Organization. APOllO devoted to developing detection technology by uti- lizing antibodies. In 2015, We cooperated with iGEM with Synthetic Biology to develop a brand new detection platform.

What's new

APOllO E.Cotector:
Our organization create a customized scFv detection platform by co-transforming any desired plasmid. ScFv utilizing antigen -antibody interaction can act as probes. Our E.Cotector can therefore have the function of a detector.

What do we care

In 2015, we focus on helping doctors select the appropriate candidates for monoclonal-antibody targeted drug for patient's treatment in a more inexpensive way. If the cost for diagnosis decreases, more patients can afford it. Therefore, more patients can be prescribed and treated, lowering the mortality rate of cancer.